No English Funding For Lymphoma Drugs Ledaga and Poteligeo
Issues With Clinical Trial Design Among Issues Of Concern To HTA Body NICE
Executive Summary
Limitations in the design of the clinical trials that were carried out for each drug are among the concerns highlighted by the health technology assessment body in two interim guidances that are now out for consultation.